General Public
You are here
The Clinical Trials Network for the Prevention and Early Treatment of Acute Lung Injury (PETAL Network) is a network of 12 Clinical Centers (CC) and 1 Clinical Coordinating Center (CCC) funded by the National Heart, Lung, and Blood Institute (NHLBI) to develop and conduct randomized controlled clinical trials to prevent or treat, and/or improve the outcome of patients who have, or who are at risk for, Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Primary studies
Ancillary studies
-
PRIMROSE: Effect of randomization to neuromuscular blockade on physical functional impairment and recovery in ARDS
-
Provider perceptions of neuromuscular blockade in ARDS (PETE ROSE)
-
Re-Evaluation of Systemic Early Neuromuscular Blockade and TransThoracic Ultrasound Assessment of the Diaphragm (ROSETTA)
-
RED ROSE (Reconciling Expected vs Delivered Tidal Volumes in ROSE with Patient-ventilator Dyssynchrony)
-
ROSE-Transthoracic Ultrasound Assessment of the Diaphragm (ROSETTA)
News & Announcements
As physicians and scientists, our goal is to advance the care and treatment of sepsis, which claims the lives of more than 250,000 Americans every year. This study compares two approaches for the treatment of septic shock that are both currently in widespread use.
It is with the heaviest of hearts and deepest sorrow that the PETAL Network notes the passing of Arthur “Art” P. Wheeler on December 17th, 2015.